Select any link to see items in a related category.
more general categories information about this item 03. Biological Effects of Specific Chemicals 03. Biological Effects of Specific Chemicals biochemical uses [CHEBI:52206] (3306) enzyme inhibitor [CHEBI:23924] (825) peptidase inhibitor [CHEBI:60258] (10) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) 08. Chemical Category 08. Chemical Category main group molecular entity [CHEBI:33579] (25650) p-block molecular entity [CHEBI:33675] (25343) halogen molecular entity [CHEBI:24471] (1475) fluorine molecular entity [CHEBI:24062] (288) organofluorine compound [CHEBI:37143] (275) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) halide [CHEBI:37578] (1402) organohalogen compound [CHEBI:36684] (976) organofluorine compound [CHEBI:37143] (275) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) pnictogen molecular entity [CHEBI:33302] (10027) nitrogen molecular entity [CHEBI:51143] (7930) organonitrogen compound [CHEBI:35352] (6705) organonitrogen heterocyclic compound [CHEBI:38101] (3202) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) carbon group molecular entity [CHEBI:33582] (23847) organic molecular entity [CHEBI:50860] (23769) heteroorganic entity [CHEBI:33285] (15197) organic heterocyclic compound [CHEBI:24532] (5243) organonitrogen heterocyclic compound [CHEBI:38101] (3202) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic heteropolycyclic compound [CHEBI:38166] (2613) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organonitrogen compound [CHEBI:35352] (6705) organonitrogen heterocyclic compound [CHEBI:38101] (3202) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organohalogen compound [CHEBI:36684] (976) organofluorine compound [CHEBI:37143] (275) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic molecule [CHEBI:72695] (11399) organic cyclic compound [CHEBI:33832] (7633) organic heterocyclic compound [CHEBI:24532] (5243) organonitrogen heterocyclic compound [CHEBI:38101] (3202) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic heteropolycyclic compound [CHEBI:38166] (2613) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) polyatomic entity [CHEBI:36357] (18777) molecule [CHEBI:25367] (11520) cyclic compound [CHEBI:33595] (7817) polycyclic compound [CHEBI:33635] (4078) heteropolycyclic compound [CHEBI:33671] (2613) organic heteropolycyclic compound [CHEBI:38166] (2613) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) bicyclic compound [CHEBI:33636] (1511) heterobicyclic compound [CHEBI:33672] (1315) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic cyclic compound [CHEBI:33832] (7633) organic heterocyclic compound [CHEBI:24532] (5243) organonitrogen heterocyclic compound [CHEBI:38101] (3202) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic heteropolycyclic compound [CHEBI:38166] (2613) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) ring assembly [CHEBI:36820] (165) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) heterocyclic compound [CHEBI:5686] (5275) organic heterocyclic compound [CHEBI:24532] (5243) organonitrogen heterocyclic compound [CHEBI:38101] (3202) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic heteropolycyclic compound [CHEBI:38166] (2613) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) heteropolycyclic compound [CHEBI:33671] (2613) organic heteropolycyclic compound [CHEBI:38166] (2613) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) heterobicyclic compound [CHEBI:33672] (1315) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic molecule [CHEBI:72695] (11399) organic cyclic compound [CHEBI:33832] (7633) organic heterocyclic compound [CHEBI:24532] (5243) organonitrogen heterocyclic compound [CHEBI:38101] (3202) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) organic heteropolycyclic compound [CHEBI:38166] (2613) organic heterobicyclic compound [CHEBI:27171] (1315) triazolopyrazine [CHEBI:48277] (2) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) heteroatomic molecular entity [CHEBI:37577] (13672) halide [CHEBI:37578] (1402) organohalogen compound [CHEBI:36684] (976) organofluorine compound [CHEBI:37143] (275) (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine [CHEBI:39959] (1) ChEBI Compound Accession Identifier: [CHEBI:39959] ChEBI Compound Description: A triazolopyrazine that is a rigid cyclohexylamine analogue of sitagliptin. ChEBI Compound Identification Number: 39959 ChEBI InChI Value: InChI=1S/C18H19F6N5/c19-12-7-14(21)13(20)6-11(12)10-2-1-9(5-15(10)25)28-3-4-29-16(8-28)26-27-17(29)18(22,23)24/h6-7,9-10,15H,1-5,8,25H2/t9-,10+,15-/m0/s1 ChEBI InChIKey Value: CNKRZILQBKJWDS-WMFXKJRFSA-N ChEBI Compound Name: (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine ChEBI SMILES Value: [H][C@@]1(CC[C@@]([H])([C@@H](N)C1)c1cc(F)c(F)cc1F)N1CCn2c(C1)nnc2C(F)(F)F ChEBI Substance ID: 135668199 ChEBI URL: ChEBI:39959 ChemSpider ID: 9713772 Ontomatica Chemical Accession Key (OnChAKey): CNKRZILQBKJWDS_WMFXKJRFSA_N_000_000000 PubChem Compound ID: 11538992